Review



rabbit anti-mouse ki67 ab  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher rabbit anti-mouse ki67 ab
    ( a ) Schematic representation of primers for genotyping and targeting strategy. ( b ) miR-31 genotyping using P1/P2, 1,064 bp band for miR-31 fl/fl and 235 bp band for miR-31 fl/fl /K5-Cre (cKO). DNA samples were prepared from total skin. ( c ) Cre-mediated tissue-specific deletion of miR-31 in epidermis. DNA samples were prepared from either epidermis or dermis. ( d ) miR-31 expression in epidermis derived from miR-31 fl/fl and cKO mice. ( e ) Phenotypic presentation of mouse back skin for miR-31 fl/fl or cKO mice treated with IMQ or vehicle for 7 days. ( f ) Splenomegaly and lymphadenopathy in miR-31 fl/fl or cKO mice treated with IMQ or vehicle for 7 days. Data are representative of more than five mice. ( g ) Skin thickness was measured on the days indicated. Symbols represent mean skin thickness±s.e.m. for five to six mice per group. ( h ) H&E staining of the back skin of miR-31 fl/fl or cKO mice treated with IMQ or vehicle. Dotted line indicates the border between the epidermis and the dermis. Scale bar, 100 μm. ( i ) Acanthosis of miR-31 fl/fl or cKO mice treated with IMQ or vehicle. ( j ) Dermal cellular infiltrates of miR-31 fl/fl or cKO mice treated with IMQ. ( k ) Immunostaining of <t>Ki67</t> in lesional skin derived from miR-31 fl/fl (left panel) or cKO (right panel) mice treated with IMQ. Scale bar, 100 μm. ( l ) Quantitation of Ki67 + cells in epidermis. For all measurements, numbers of specifically stained Ki67 + cells in epidermis counted in three high-power fields for each section were used. ( m ) qPCR analysis of epidermal differentiation markers (Keratin 10, Loricrin and Filaggrin) in miR-31 fl/fl or cKO mice treated with IMQ or vehicle. Results ( d , m ) are presented as the ratio of miRNA to the small nuclear RNA U6 or of mRNA to the β-actin, relative to that in miR-31 fl/fl mice. * P <0.05, ** P <0.01, *** P <0.001, two-tailed Student's t -test for d , i , j , l , m , one-way ANOVA for g . Data ( g , i , j , l , m ) are representative of two independent experiments with four to six mice per group in each (mean and s.e.m.).
    Rabbit Anti Mouse Ki67 Ab, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti-mouse+ki67+ab/ki67+antibody/pmc04506511-211-22-26
    Average 90 stars, based on 1 article reviews
    rabbit anti-mouse ki67 ab - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis"

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis

    Journal: Nature Communications

    doi: 10.1038/ncomms8652

    ( a ) Schematic representation of primers for genotyping and targeting strategy. ( b ) miR-31 genotyping using P1/P2, 1,064 bp band for miR-31 fl/fl and 235 bp band for miR-31 fl/fl /K5-Cre (cKO). DNA samples were prepared from total skin. ( c ) Cre-mediated tissue-specific deletion of miR-31 in epidermis. DNA samples were prepared from either epidermis or dermis. ( d ) miR-31 expression in epidermis derived from miR-31 fl/fl and cKO mice. ( e ) Phenotypic presentation of mouse back skin for miR-31 fl/fl or cKO mice treated with IMQ or vehicle for 7 days. ( f ) Splenomegaly and lymphadenopathy in miR-31 fl/fl or cKO mice treated with IMQ or vehicle for 7 days. Data are representative of more than five mice. ( g ) Skin thickness was measured on the days indicated. Symbols represent mean skin thickness±s.e.m. for five to six mice per group. ( h ) H&E staining of the back skin of miR-31 fl/fl or cKO mice treated with IMQ or vehicle. Dotted line indicates the border between the epidermis and the dermis. Scale bar, 100 μm. ( i ) Acanthosis of miR-31 fl/fl or cKO mice treated with IMQ or vehicle. ( j ) Dermal cellular infiltrates of miR-31 fl/fl or cKO mice treated with IMQ. ( k ) Immunostaining of Ki67 in lesional skin derived from miR-31 fl/fl (left panel) or cKO (right panel) mice treated with IMQ. Scale bar, 100 μm. ( l ) Quantitation of Ki67 + cells in epidermis. For all measurements, numbers of specifically stained Ki67 + cells in epidermis counted in three high-power fields for each section were used. ( m ) qPCR analysis of epidermal differentiation markers (Keratin 10, Loricrin and Filaggrin) in miR-31 fl/fl or cKO mice treated with IMQ or vehicle. Results ( d , m ) are presented as the ratio of miRNA to the small nuclear RNA U6 or of mRNA to the β-actin, relative to that in miR-31 fl/fl mice. * P <0.05, ** P <0.01, *** P <0.001, two-tailed Student's t -test for d , i , j , l , m , one-way ANOVA for g . Data ( g , i , j , l , m ) are representative of two independent experiments with four to six mice per group in each (mean and s.e.m.).
    Figure Legend Snippet: ( a ) Schematic representation of primers for genotyping and targeting strategy. ( b ) miR-31 genotyping using P1/P2, 1,064 bp band for miR-31 fl/fl and 235 bp band for miR-31 fl/fl /K5-Cre (cKO). DNA samples were prepared from total skin. ( c ) Cre-mediated tissue-specific deletion of miR-31 in epidermis. DNA samples were prepared from either epidermis or dermis. ( d ) miR-31 expression in epidermis derived from miR-31 fl/fl and cKO mice. ( e ) Phenotypic presentation of mouse back skin for miR-31 fl/fl or cKO mice treated with IMQ or vehicle for 7 days. ( f ) Splenomegaly and lymphadenopathy in miR-31 fl/fl or cKO mice treated with IMQ or vehicle for 7 days. Data are representative of more than five mice. ( g ) Skin thickness was measured on the days indicated. Symbols represent mean skin thickness±s.e.m. for five to six mice per group. ( h ) H&E staining of the back skin of miR-31 fl/fl or cKO mice treated with IMQ or vehicle. Dotted line indicates the border between the epidermis and the dermis. Scale bar, 100 μm. ( i ) Acanthosis of miR-31 fl/fl or cKO mice treated with IMQ or vehicle. ( j ) Dermal cellular infiltrates of miR-31 fl/fl or cKO mice treated with IMQ. ( k ) Immunostaining of Ki67 in lesional skin derived from miR-31 fl/fl (left panel) or cKO (right panel) mice treated with IMQ. Scale bar, 100 μm. ( l ) Quantitation of Ki67 + cells in epidermis. For all measurements, numbers of specifically stained Ki67 + cells in epidermis counted in three high-power fields for each section were used. ( m ) qPCR analysis of epidermal differentiation markers (Keratin 10, Loricrin and Filaggrin) in miR-31 fl/fl or cKO mice treated with IMQ or vehicle. Results ( d , m ) are presented as the ratio of miRNA to the small nuclear RNA U6 or of mRNA to the β-actin, relative to that in miR-31 fl/fl mice. * P <0.05, ** P <0.01, *** P <0.001, two-tailed Student's t -test for d , i , j , l , m , one-way ANOVA for g . Data ( g , i , j , l , m ) are representative of two independent experiments with four to six mice per group in each (mean and s.e.m.).

    Techniques Used: Expressing, Derivative Assay, Staining, Immunostaining, Quantitation Assay, Two Tailed Test

    ( a , b ) Western blotting of ppp6c expression in the epidermis of normal skin derived from four healthy individuals (Ctr-1 to 4) or in psoriatic lesions derived from four patients with psoriasis (Pso-1 to 4). ( c ) Immunohistochemical staining of ppp6c in skin sections derived from healthy or psoriatic skin. Scale bar, 100 μm. ( d ) Primary mouse keratinocytes were transfected with scramble siRNA (Ctr) or with ppp6c siRNA (siRNA). Cell lysates were immunoblotted with anti-ppp6c or anti-actin. ( e ) Cell cycle analysis of mouse primary keratinocytes transfected with scrambled siRNA or ppp6c siRNA. ( f ) Western blotting of ppp6c expression in epidermis derived from lentiviral shRNA-control (LV-Ctr) or lentiviral shRNA-ppp6c (LV-shRNA) treated mice. ( g ) H&E staining of the back skin injected with LV-Ctr or LV-shRNA in mice applied with IMQ. Dotted line indicates the border between the epidermis and dermis. Scale bar, 100 μm. ( h ) Acanthosis of the back skin injected with LV-Ctr or LV-shRNA in mice applied with IMQ. ( i ) Immunohistochemical staining of Ki67 in skin sections derived from mice injected with LV-Ctr or LV-shRNA prior to IMQ painting. Dotted line indicates the border between the epidermis and dermis. Scale bar, 50 μm. Values ( a , d , f ) were expressed as fold changes relative to Ctr-1 ( a ), to scramble siRNA ( d ), or to lentiviral shRNA-control ( f ), and normalized to β-actin. * P <0.05, ** P <0.01, two-tailed Student's t -test. Data ( c – i ) are representative of two independent experiments with three to five samples per group.
    Figure Legend Snippet: ( a , b ) Western blotting of ppp6c expression in the epidermis of normal skin derived from four healthy individuals (Ctr-1 to 4) or in psoriatic lesions derived from four patients with psoriasis (Pso-1 to 4). ( c ) Immunohistochemical staining of ppp6c in skin sections derived from healthy or psoriatic skin. Scale bar, 100 μm. ( d ) Primary mouse keratinocytes were transfected with scramble siRNA (Ctr) or with ppp6c siRNA (siRNA). Cell lysates were immunoblotted with anti-ppp6c or anti-actin. ( e ) Cell cycle analysis of mouse primary keratinocytes transfected with scrambled siRNA or ppp6c siRNA. ( f ) Western blotting of ppp6c expression in epidermis derived from lentiviral shRNA-control (LV-Ctr) or lentiviral shRNA-ppp6c (LV-shRNA) treated mice. ( g ) H&E staining of the back skin injected with LV-Ctr or LV-shRNA in mice applied with IMQ. Dotted line indicates the border between the epidermis and dermis. Scale bar, 100 μm. ( h ) Acanthosis of the back skin injected with LV-Ctr or LV-shRNA in mice applied with IMQ. ( i ) Immunohistochemical staining of Ki67 in skin sections derived from mice injected with LV-Ctr or LV-shRNA prior to IMQ painting. Dotted line indicates the border between the epidermis and dermis. Scale bar, 50 μm. Values ( a , d , f ) were expressed as fold changes relative to Ctr-1 ( a ), to scramble siRNA ( d ), or to lentiviral shRNA-control ( f ), and normalized to β-actin. * P <0.05, ** P <0.01, two-tailed Student's t -test. Data ( c – i ) are representative of two independent experiments with three to five samples per group.

    Techniques Used: Western Blot, Expressing, Derivative Assay, Immunohistochemical staining, Staining, Transfection, Cell Cycle Assay, shRNA, Control, Injection, Two Tailed Test

    ( a ) Undifferentiated NHEK proliferation induced by various concentrations of IL-6 for 24 h, and analysed by BrdU incorporation assay. ( b ) NHEK were transfected with scramble siRNA (Ctr) or with p65 siRNA (p65 siRNA). Cell cycle analysis of NHEK or transfected NHEK treated without or with IL-6 for 24 h. ( c ) In vitro wound healing rate of NHEK treated without or with IL-6 for 16 h. ( d , e ) Three-dimensional organotypic culture of HaCaT keratinocytes treated without or with IL-6. Scale bar, 100 μm. ( f ) 1 μg recombinant mouse IL-6 (in 25 μl PBS) or PBS was injected i.d. in ears of C57BL/6J mice. Ear sections were prepared for Ki67 staining 3 days after IL-6 administration. Scale bar, 100 μm. ( g ) NHEK were transfected with scramble siRNA (Ctr) or with p65 siRNA (p65 siRNA). Western blotting of ppp6c expression in NHEK with or without IL-6 treatment for 24 h. ( h ) Cell cycle analysis of primary mouse keratinocytes derived from miR-31 fl/fl or cKO mice in absence or presence of IL-6. Values were expressed as fold changes relative to non-stimulated HaCaT keratinocytes ( e ) or to non-stimulated NHEK ( g ) and normalized to β-actin. IL-6 was used at the concentration of 50 ng ml −1 ( b – e , g , h ). ** P <0.01, *** P <0.001, two-tailed Student's t -test. Data are representative of at least two independent experiments.
    Figure Legend Snippet: ( a ) Undifferentiated NHEK proliferation induced by various concentrations of IL-6 for 24 h, and analysed by BrdU incorporation assay. ( b ) NHEK were transfected with scramble siRNA (Ctr) or with p65 siRNA (p65 siRNA). Cell cycle analysis of NHEK or transfected NHEK treated without or with IL-6 for 24 h. ( c ) In vitro wound healing rate of NHEK treated without or with IL-6 for 16 h. ( d , e ) Three-dimensional organotypic culture of HaCaT keratinocytes treated without or with IL-6. Scale bar, 100 μm. ( f ) 1 μg recombinant mouse IL-6 (in 25 μl PBS) or PBS was injected i.d. in ears of C57BL/6J mice. Ear sections were prepared for Ki67 staining 3 days after IL-6 administration. Scale bar, 100 μm. ( g ) NHEK were transfected with scramble siRNA (Ctr) or with p65 siRNA (p65 siRNA). Western blotting of ppp6c expression in NHEK with or without IL-6 treatment for 24 h. ( h ) Cell cycle analysis of primary mouse keratinocytes derived from miR-31 fl/fl or cKO mice in absence or presence of IL-6. Values were expressed as fold changes relative to non-stimulated HaCaT keratinocytes ( e ) or to non-stimulated NHEK ( g ) and normalized to β-actin. IL-6 was used at the concentration of 50 ng ml −1 ( b – e , g , h ). ** P <0.01, *** P <0.001, two-tailed Student's t -test. Data are representative of at least two independent experiments.

    Techniques Used: BrdU Incorporation Assay, Transfection, Cell Cycle Assay, In Vitro, Recombinant, Injection, Staining, Western Blot, Expressing, Derivative Assay, Concentration Assay, Two Tailed Test

    Mice were injected subcutaneously with an irrelevant antagomir (NC) or an antagomir to miR-31 (anti-miR-31). The first injection was administered 3 days before the application of IMQ and thereafter was performed every other day until the end of the experiment. ( a ) H&E staining of the back skin derived from mice injected with NC (upper panel) or anti-miR-31 (lower panel). Scale bar, 100 μm. ( b , c ) Acanthosis and dermal cellular infiltrates were quantitated for mice treated with NC or anti-miR-31. ( d , e ) Ppp6c mRNA and protein levels in NC- or anti-miR-31-treated mice. ( f , g ) Immunohistochemical staining of ppp6c or Ki67 in skin sections derived from NC- or anti-miR-31-treated mice after induction of skin phenotype by IMQ ( n =8–9). Scale bar, 50 μm ( f ) or 100 μm ( g ). For all measurements ( c ), the median number of specifically stained dermal nucleated cells was counted in three high-power fields per section. Results ( d ) are presented as the ratio of mRNA to the β-actin, relative to that in NC-treated mice. * P <0.05, *** P <0.001, two-tailed Student's t -test. Data ( a – g ) are representative of at least two independent experiments with four to nine samples per group in each (mean and s.e.m.).
    Figure Legend Snippet: Mice were injected subcutaneously with an irrelevant antagomir (NC) or an antagomir to miR-31 (anti-miR-31). The first injection was administered 3 days before the application of IMQ and thereafter was performed every other day until the end of the experiment. ( a ) H&E staining of the back skin derived from mice injected with NC (upper panel) or anti-miR-31 (lower panel). Scale bar, 100 μm. ( b , c ) Acanthosis and dermal cellular infiltrates were quantitated for mice treated with NC or anti-miR-31. ( d , e ) Ppp6c mRNA and protein levels in NC- or anti-miR-31-treated mice. ( f , g ) Immunohistochemical staining of ppp6c or Ki67 in skin sections derived from NC- or anti-miR-31-treated mice after induction of skin phenotype by IMQ ( n =8–9). Scale bar, 50 μm ( f ) or 100 μm ( g ). For all measurements ( c ), the median number of specifically stained dermal nucleated cells was counted in three high-power fields per section. Results ( d ) are presented as the ratio of mRNA to the β-actin, relative to that in NC-treated mice. * P <0.05, *** P <0.001, two-tailed Student's t -test. Data ( a – g ) are representative of at least two independent experiments with four to nine samples per group in each (mean and s.e.m.).

    Techniques Used: Injection, Staining, Derivative Assay, Immunohistochemical staining, Two Tailed Test

    Related Articles

    Expressing:

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis
    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    Derivative Assay:

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis
    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    Staining:

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis
    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    Immunostaining:

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis
    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    Quantitation Assay:

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis
    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    Two Tailed Test:

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis
    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    Western Blot:

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis
    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    Immunohistochemical staining:

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis
    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    Transfection:

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis
    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    Cell Cycle Assay:

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis
    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    shRNA:

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis
    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    Control:

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis
    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    Injection:

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis
    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    BrdU Incorporation Assay:

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis
    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    In Vitro:

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis
    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    Recombinant:

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis
    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    Concentration Assay:

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis
    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.



    Similar Products

    97
    Cell Signaling Technology Inc anti mouse ki67 ab
    Anti Mouse Ki67 Ab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti-mouse+ki67+ab/Ki-67+Rabbit+mAb/pm37269543-83-13-19
    Average 97 stars, based on 1 article reviews
    anti mouse ki67 ab - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc rabbit anti-mouse ki67 ab #12202
    Rabbit Anti Mouse Ki67 Ab #12202, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti-mouse+ki67+ab/ki67+antibody/pm37269543-83-12-19
    Average 90 stars, based on 1 article reviews
    rabbit anti-mouse ki67 ab #12202 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc anti ki67 ab staining
    miR-221 downregulates P27 and increases cellular proliferation in vitro Rat ventricular myoblast H9c2 cells were transfected with 25 nM miR-221 mimics (miR-221) or control (MC) for 24 h and subjected to 20 h hypoxia/2 h re-oxygenation (H/R). The normoxia groups were incubated under normal culture conditions for an equal duration. p27 was measured by RT-qPCR (A) and western blot (B). (C) Cell proliferation was measured by <t>ki67</t> staining (i) and cell count (ii). (D) p27 cDNA plasmid was co-transfected with mimics for phenotype rescue. The effects of P27 overexpression were validated by western blot (i), ki67 staining (ii), and cell count (iii). Data are expressed as mean ± SD. ∗p < 0.05, ∗∗∗p < 0.001 versus MC, #p < 0.05 versus miR-221 by one-way ANOVA with Bonferroni post hoc analysis. Experiments performed three times in triplicate.
    Anti Ki67 Ab Staining, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti-mouse+ki67+ab/Mouse+Anti-rabbit+IgG+(Conformation+Specific)+mAb/pmc08728526-272-19-24
    Average 97 stars, based on 1 article reviews
    anti ki67 ab staining - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc monoclonal anti mouse ki67 ab
    miR-221 downregulates P27 and increases cellular proliferation in vitro Rat ventricular myoblast H9c2 cells were transfected with 25 nM miR-221 mimics (miR-221) or control (MC) for 24 h and subjected to 20 h hypoxia/2 h re-oxygenation (H/R). The normoxia groups were incubated under normal culture conditions for an equal duration. p27 was measured by RT-qPCR (A) and western blot (B). (C) Cell proliferation was measured by <t>ki67</t> staining (i) and cell count (ii). (D) p27 cDNA plasmid was co-transfected with mimics for phenotype rescue. The effects of P27 overexpression were validated by western blot (i), ki67 staining (ii), and cell count (iii). Data are expressed as mean ± SD. ∗p < 0.05, ∗∗∗p < 0.001 versus MC, #p < 0.05 versus miR-221 by one-way ANOVA with Bonferroni post hoc analysis. Experiments performed three times in triplicate.
    Monoclonal Anti Mouse Ki67 Ab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti-mouse+ki67+ab/Ki-67+Rabbit+mAb/pmc05768393-174-2-5
    Average 97 stars, based on 1 article reviews
    monoclonal anti mouse ki67 ab - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    90
    Thermo Fisher rabbit anti-mouse ki67 ab
    ( a ) Schematic representation of primers for genotyping and targeting strategy. ( b ) miR-31 genotyping using P1/P2, 1,064 bp band for miR-31 fl/fl and 235 bp band for miR-31 fl/fl /K5-Cre (cKO). DNA samples were prepared from total skin. ( c ) Cre-mediated tissue-specific deletion of miR-31 in epidermis. DNA samples were prepared from either epidermis or dermis. ( d ) miR-31 expression in epidermis derived from miR-31 fl/fl and cKO mice. ( e ) Phenotypic presentation of mouse back skin for miR-31 fl/fl or cKO mice treated with IMQ or vehicle for 7 days. ( f ) Splenomegaly and lymphadenopathy in miR-31 fl/fl or cKO mice treated with IMQ or vehicle for 7 days. Data are representative of more than five mice. ( g ) Skin thickness was measured on the days indicated. Symbols represent mean skin thickness±s.e.m. for five to six mice per group. ( h ) H&E staining of the back skin of miR-31 fl/fl or cKO mice treated with IMQ or vehicle. Dotted line indicates the border between the epidermis and the dermis. Scale bar, 100 μm. ( i ) Acanthosis of miR-31 fl/fl or cKO mice treated with IMQ or vehicle. ( j ) Dermal cellular infiltrates of miR-31 fl/fl or cKO mice treated with IMQ. ( k ) Immunostaining of <t>Ki67</t> in lesional skin derived from miR-31 fl/fl (left panel) or cKO (right panel) mice treated with IMQ. Scale bar, 100 μm. ( l ) Quantitation of Ki67 + cells in epidermis. For all measurements, numbers of specifically stained Ki67 + cells in epidermis counted in three high-power fields for each section were used. ( m ) qPCR analysis of epidermal differentiation markers (Keratin 10, Loricrin and Filaggrin) in miR-31 fl/fl or cKO mice treated with IMQ or vehicle. Results ( d , m ) are presented as the ratio of miRNA to the small nuclear RNA U6 or of mRNA to the β-actin, relative to that in miR-31 fl/fl mice. * P <0.05, ** P <0.01, *** P <0.001, two-tailed Student's t -test for d , i , j , l , m , one-way ANOVA for g . Data ( g , i , j , l , m ) are representative of two independent experiments with four to six mice per group in each (mean and s.e.m.).
    Rabbit Anti Mouse Ki67 Ab, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti-mouse+ki67+ab/ki67+antibody/pmc04506511-211-22-26
    Average 90 stars, based on 1 article reviews
    rabbit anti-mouse ki67 ab - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher primary ab against rabbit anti-human/mouse ki67 (sp6)
    ( a ) Schematic representation of primers for genotyping and targeting strategy. ( b ) miR-31 genotyping using P1/P2, 1,064 bp band for miR-31 fl/fl and 235 bp band for miR-31 fl/fl /K5-Cre (cKO). DNA samples were prepared from total skin. ( c ) Cre-mediated tissue-specific deletion of miR-31 in epidermis. DNA samples were prepared from either epidermis or dermis. ( d ) miR-31 expression in epidermis derived from miR-31 fl/fl and cKO mice. ( e ) Phenotypic presentation of mouse back skin for miR-31 fl/fl or cKO mice treated with IMQ or vehicle for 7 days. ( f ) Splenomegaly and lymphadenopathy in miR-31 fl/fl or cKO mice treated with IMQ or vehicle for 7 days. Data are representative of more than five mice. ( g ) Skin thickness was measured on the days indicated. Symbols represent mean skin thickness±s.e.m. for five to six mice per group. ( h ) H&E staining of the back skin of miR-31 fl/fl or cKO mice treated with IMQ or vehicle. Dotted line indicates the border between the epidermis and the dermis. Scale bar, 100 μm. ( i ) Acanthosis of miR-31 fl/fl or cKO mice treated with IMQ or vehicle. ( j ) Dermal cellular infiltrates of miR-31 fl/fl or cKO mice treated with IMQ. ( k ) Immunostaining of <t>Ki67</t> in lesional skin derived from miR-31 fl/fl (left panel) or cKO (right panel) mice treated with IMQ. Scale bar, 100 μm. ( l ) Quantitation of Ki67 + cells in epidermis. For all measurements, numbers of specifically stained Ki67 + cells in epidermis counted in three high-power fields for each section were used. ( m ) qPCR analysis of epidermal differentiation markers (Keratin 10, Loricrin and Filaggrin) in miR-31 fl/fl or cKO mice treated with IMQ or vehicle. Results ( d , m ) are presented as the ratio of miRNA to the small nuclear RNA U6 or of mRNA to the β-actin, relative to that in miR-31 fl/fl mice. * P <0.05, ** P <0.01, *** P <0.001, two-tailed Student's t -test for d , i , j , l , m , one-way ANOVA for g . Data ( g , i , j , l , m ) are representative of two independent experiments with four to six mice per group in each (mean and s.e.m.).
    Primary Ab Against Rabbit Anti Human/Mouse Ki67 (Sp6), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti-mouse+ki67+ab/ki67+antibody/10__1172_slash_jci39087-290-10-13
    Average 90 stars, based on 1 article reviews
    primary ab against rabbit anti-human/mouse ki67 (sp6) - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    miR-221 downregulates P27 and increases cellular proliferation in vitro Rat ventricular myoblast H9c2 cells were transfected with 25 nM miR-221 mimics (miR-221) or control (MC) for 24 h and subjected to 20 h hypoxia/2 h re-oxygenation (H/R). The normoxia groups were incubated under normal culture conditions for an equal duration. p27 was measured by RT-qPCR (A) and western blot (B). (C) Cell proliferation was measured by ki67 staining (i) and cell count (ii). (D) p27 cDNA plasmid was co-transfected with mimics for phenotype rescue. The effects of P27 overexpression were validated by western blot (i), ki67 staining (ii), and cell count (iii). Data are expressed as mean ± SD. ∗p < 0.05, ∗∗∗p < 0.001 versus MC, #p < 0.05 versus miR-221 by one-way ANOVA with Bonferroni post hoc analysis. Experiments performed three times in triplicate.

    Journal: Molecular Therapy. Nucleic Acids

    Article Title: Loss of full-length pumilio 1 abrogates miRNA-221-induced gene p27 silencing-mediated cell proliferation in the heart

    doi: 10.1016/j.omtn.2021.12.012

    Figure Lengend Snippet: miR-221 downregulates P27 and increases cellular proliferation in vitro Rat ventricular myoblast H9c2 cells were transfected with 25 nM miR-221 mimics (miR-221) or control (MC) for 24 h and subjected to 20 h hypoxia/2 h re-oxygenation (H/R). The normoxia groups were incubated under normal culture conditions for an equal duration. p27 was measured by RT-qPCR (A) and western blot (B). (C) Cell proliferation was measured by ki67 staining (i) and cell count (ii). (D) p27 cDNA plasmid was co-transfected with mimics for phenotype rescue. The effects of P27 overexpression were validated by western blot (i), ki67 staining (ii), and cell count (iii). Data are expressed as mean ± SD. ∗p < 0.05, ∗∗∗p < 0.001 versus MC, #p < 0.05 versus miR-221 by one-way ANOVA with Bonferroni post hoc analysis. Experiments performed three times in triplicate.

    Article Snippet: Briefly, cells were trypsinized, fixed, and permeabilized (eBioscience Intracellular Fixation & Permeabilization Buffer Set, Thermo Fisher Scientific, Singapore) for anti-ki67 Ab staining (clone 8D5, Cell Signaling Technology, Research Biolabs, Singapore) and anti-mouse IgG-PE (Invitrogen, Thermo Fisher Scientific, Singapore), followed by flow cytometry on MUSE cell analyzer (Merck, Singapore).

    Techniques: In Vitro, Transfection, Control, Incubation, Quantitative RT-PCR, Western Blot, Staining, Cell Counting, Plasmid Preparation, Over Expression

    Stress and repeated miR-221 treatment do not induce FL PUM1 expression or p27 regulation in rat MI heart (A) Rat hearts with MI were harvested at 48 h after surgery (MId2) and dissected by the infarct, border, and remote zones (Inf., Bor., Rem., respectively). PUM1 protein expression was assessed with western blot. HeLa cell lysate was used as a positive control. (B) Mimics of miR-221 were i.v. injected at 1 mg/kg immediately after surgery and tissue was harvested at MId2. A second injection was given at day 3 and tissue was harvested at MId7. miR-221 overexpression was measured by stem-loop qPCR. Results are presented as fold change over MI control. P27 expression in MI control and miR-221 mimic-treated rat hearts was measured by (C) RT-qPCR and (D) western blot. (E) Immunofluorescence staining of the heart sections (MId7) with three colors: cell proliferation marker ki67 (red), fibrosis marker α-SMA (green), nuclei stain DAPI (blue) (i). Scale bar, 200 μm. Results were analyzed as ki67% positive nuclei and normalized to MI control (ii). n = 5 animals for each group.

    Journal: Molecular Therapy. Nucleic Acids

    Article Title: Loss of full-length pumilio 1 abrogates miRNA-221-induced gene p27 silencing-mediated cell proliferation in the heart

    doi: 10.1016/j.omtn.2021.12.012

    Figure Lengend Snippet: Stress and repeated miR-221 treatment do not induce FL PUM1 expression or p27 regulation in rat MI heart (A) Rat hearts with MI were harvested at 48 h after surgery (MId2) and dissected by the infarct, border, and remote zones (Inf., Bor., Rem., respectively). PUM1 protein expression was assessed with western blot. HeLa cell lysate was used as a positive control. (B) Mimics of miR-221 were i.v. injected at 1 mg/kg immediately after surgery and tissue was harvested at MId2. A second injection was given at day 3 and tissue was harvested at MId7. miR-221 overexpression was measured by stem-loop qPCR. Results are presented as fold change over MI control. P27 expression in MI control and miR-221 mimic-treated rat hearts was measured by (C) RT-qPCR and (D) western blot. (E) Immunofluorescence staining of the heart sections (MId7) with three colors: cell proliferation marker ki67 (red), fibrosis marker α-SMA (green), nuclei stain DAPI (blue) (i). Scale bar, 200 μm. Results were analyzed as ki67% positive nuclei and normalized to MI control (ii). n = 5 animals for each group.

    Article Snippet: Briefly, cells were trypsinized, fixed, and permeabilized (eBioscience Intracellular Fixation & Permeabilization Buffer Set, Thermo Fisher Scientific, Singapore) for anti-ki67 Ab staining (clone 8D5, Cell Signaling Technology, Research Biolabs, Singapore) and anti-mouse IgG-PE (Invitrogen, Thermo Fisher Scientific, Singapore), followed by flow cytometry on MUSE cell analyzer (Merck, Singapore).

    Techniques: Expressing, Western Blot, Positive Control, Injection, Over Expression, Control, Quantitative RT-PCR, Immunofluorescence, Staining, Marker

    ( a ) Schematic representation of primers for genotyping and targeting strategy. ( b ) miR-31 genotyping using P1/P2, 1,064 bp band for miR-31 fl/fl and 235 bp band for miR-31 fl/fl /K5-Cre (cKO). DNA samples were prepared from total skin. ( c ) Cre-mediated tissue-specific deletion of miR-31 in epidermis. DNA samples were prepared from either epidermis or dermis. ( d ) miR-31 expression in epidermis derived from miR-31 fl/fl and cKO mice. ( e ) Phenotypic presentation of mouse back skin for miR-31 fl/fl or cKO mice treated with IMQ or vehicle for 7 days. ( f ) Splenomegaly and lymphadenopathy in miR-31 fl/fl or cKO mice treated with IMQ or vehicle for 7 days. Data are representative of more than five mice. ( g ) Skin thickness was measured on the days indicated. Symbols represent mean skin thickness±s.e.m. for five to six mice per group. ( h ) H&E staining of the back skin of miR-31 fl/fl or cKO mice treated with IMQ or vehicle. Dotted line indicates the border between the epidermis and the dermis. Scale bar, 100 μm. ( i ) Acanthosis of miR-31 fl/fl or cKO mice treated with IMQ or vehicle. ( j ) Dermal cellular infiltrates of miR-31 fl/fl or cKO mice treated with IMQ. ( k ) Immunostaining of Ki67 in lesional skin derived from miR-31 fl/fl (left panel) or cKO (right panel) mice treated with IMQ. Scale bar, 100 μm. ( l ) Quantitation of Ki67 + cells in epidermis. For all measurements, numbers of specifically stained Ki67 + cells in epidermis counted in three high-power fields for each section were used. ( m ) qPCR analysis of epidermal differentiation markers (Keratin 10, Loricrin and Filaggrin) in miR-31 fl/fl or cKO mice treated with IMQ or vehicle. Results ( d , m ) are presented as the ratio of miRNA to the small nuclear RNA U6 or of mRNA to the β-actin, relative to that in miR-31 fl/fl mice. * P <0.05, ** P <0.01, *** P <0.001, two-tailed Student's t -test for d , i , j , l , m , one-way ANOVA for g . Data ( g , i , j , l , m ) are representative of two independent experiments with four to six mice per group in each (mean and s.e.m.).

    Journal: Nature Communications

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis

    doi: 10.1038/ncomms8652

    Figure Lengend Snippet: ( a ) Schematic representation of primers for genotyping and targeting strategy. ( b ) miR-31 genotyping using P1/P2, 1,064 bp band for miR-31 fl/fl and 235 bp band for miR-31 fl/fl /K5-Cre (cKO). DNA samples were prepared from total skin. ( c ) Cre-mediated tissue-specific deletion of miR-31 in epidermis. DNA samples were prepared from either epidermis or dermis. ( d ) miR-31 expression in epidermis derived from miR-31 fl/fl and cKO mice. ( e ) Phenotypic presentation of mouse back skin for miR-31 fl/fl or cKO mice treated with IMQ or vehicle for 7 days. ( f ) Splenomegaly and lymphadenopathy in miR-31 fl/fl or cKO mice treated with IMQ or vehicle for 7 days. Data are representative of more than five mice. ( g ) Skin thickness was measured on the days indicated. Symbols represent mean skin thickness±s.e.m. for five to six mice per group. ( h ) H&E staining of the back skin of miR-31 fl/fl or cKO mice treated with IMQ or vehicle. Dotted line indicates the border between the epidermis and the dermis. Scale bar, 100 μm. ( i ) Acanthosis of miR-31 fl/fl or cKO mice treated with IMQ or vehicle. ( j ) Dermal cellular infiltrates of miR-31 fl/fl or cKO mice treated with IMQ. ( k ) Immunostaining of Ki67 in lesional skin derived from miR-31 fl/fl (left panel) or cKO (right panel) mice treated with IMQ. Scale bar, 100 μm. ( l ) Quantitation of Ki67 + cells in epidermis. For all measurements, numbers of specifically stained Ki67 + cells in epidermis counted in three high-power fields for each section were used. ( m ) qPCR analysis of epidermal differentiation markers (Keratin 10, Loricrin and Filaggrin) in miR-31 fl/fl or cKO mice treated with IMQ or vehicle. Results ( d , m ) are presented as the ratio of miRNA to the small nuclear RNA U6 or of mRNA to the β-actin, relative to that in miR-31 fl/fl mice. * P <0.05, ** P <0.01, *** P <0.001, two-tailed Student's t -test for d , i , j , l , m , one-way ANOVA for g . Data ( g , i , j , l , m ) are representative of two independent experiments with four to six mice per group in each (mean and s.e.m.).

    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    Techniques: Expressing, Derivative Assay, Staining, Immunostaining, Quantitation Assay, Two Tailed Test

    ( a , b ) Western blotting of ppp6c expression in the epidermis of normal skin derived from four healthy individuals (Ctr-1 to 4) or in psoriatic lesions derived from four patients with psoriasis (Pso-1 to 4). ( c ) Immunohistochemical staining of ppp6c in skin sections derived from healthy or psoriatic skin. Scale bar, 100 μm. ( d ) Primary mouse keratinocytes were transfected with scramble siRNA (Ctr) or with ppp6c siRNA (siRNA). Cell lysates were immunoblotted with anti-ppp6c or anti-actin. ( e ) Cell cycle analysis of mouse primary keratinocytes transfected with scrambled siRNA or ppp6c siRNA. ( f ) Western blotting of ppp6c expression in epidermis derived from lentiviral shRNA-control (LV-Ctr) or lentiviral shRNA-ppp6c (LV-shRNA) treated mice. ( g ) H&E staining of the back skin injected with LV-Ctr or LV-shRNA in mice applied with IMQ. Dotted line indicates the border between the epidermis and dermis. Scale bar, 100 μm. ( h ) Acanthosis of the back skin injected with LV-Ctr or LV-shRNA in mice applied with IMQ. ( i ) Immunohistochemical staining of Ki67 in skin sections derived from mice injected with LV-Ctr or LV-shRNA prior to IMQ painting. Dotted line indicates the border between the epidermis and dermis. Scale bar, 50 μm. Values ( a , d , f ) were expressed as fold changes relative to Ctr-1 ( a ), to scramble siRNA ( d ), or to lentiviral shRNA-control ( f ), and normalized to β-actin. * P <0.05, ** P <0.01, two-tailed Student's t -test. Data ( c – i ) are representative of two independent experiments with three to five samples per group.

    Journal: Nature Communications

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis

    doi: 10.1038/ncomms8652

    Figure Lengend Snippet: ( a , b ) Western blotting of ppp6c expression in the epidermis of normal skin derived from four healthy individuals (Ctr-1 to 4) or in psoriatic lesions derived from four patients with psoriasis (Pso-1 to 4). ( c ) Immunohistochemical staining of ppp6c in skin sections derived from healthy or psoriatic skin. Scale bar, 100 μm. ( d ) Primary mouse keratinocytes were transfected with scramble siRNA (Ctr) or with ppp6c siRNA (siRNA). Cell lysates were immunoblotted with anti-ppp6c or anti-actin. ( e ) Cell cycle analysis of mouse primary keratinocytes transfected with scrambled siRNA or ppp6c siRNA. ( f ) Western blotting of ppp6c expression in epidermis derived from lentiviral shRNA-control (LV-Ctr) or lentiviral shRNA-ppp6c (LV-shRNA) treated mice. ( g ) H&E staining of the back skin injected with LV-Ctr or LV-shRNA in mice applied with IMQ. Dotted line indicates the border between the epidermis and dermis. Scale bar, 100 μm. ( h ) Acanthosis of the back skin injected with LV-Ctr or LV-shRNA in mice applied with IMQ. ( i ) Immunohistochemical staining of Ki67 in skin sections derived from mice injected with LV-Ctr or LV-shRNA prior to IMQ painting. Dotted line indicates the border between the epidermis and dermis. Scale bar, 50 μm. Values ( a , d , f ) were expressed as fold changes relative to Ctr-1 ( a ), to scramble siRNA ( d ), or to lentiviral shRNA-control ( f ), and normalized to β-actin. * P <0.05, ** P <0.01, two-tailed Student's t -test. Data ( c – i ) are representative of two independent experiments with three to five samples per group.

    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    Techniques: Western Blot, Expressing, Derivative Assay, Immunohistochemical staining, Staining, Transfection, Cell Cycle Assay, shRNA, Control, Injection, Two Tailed Test

    ( a ) Undifferentiated NHEK proliferation induced by various concentrations of IL-6 for 24 h, and analysed by BrdU incorporation assay. ( b ) NHEK were transfected with scramble siRNA (Ctr) or with p65 siRNA (p65 siRNA). Cell cycle analysis of NHEK or transfected NHEK treated without or with IL-6 for 24 h. ( c ) In vitro wound healing rate of NHEK treated without or with IL-6 for 16 h. ( d , e ) Three-dimensional organotypic culture of HaCaT keratinocytes treated without or with IL-6. Scale bar, 100 μm. ( f ) 1 μg recombinant mouse IL-6 (in 25 μl PBS) or PBS was injected i.d. in ears of C57BL/6J mice. Ear sections were prepared for Ki67 staining 3 days after IL-6 administration. Scale bar, 100 μm. ( g ) NHEK were transfected with scramble siRNA (Ctr) or with p65 siRNA (p65 siRNA). Western blotting of ppp6c expression in NHEK with or without IL-6 treatment for 24 h. ( h ) Cell cycle analysis of primary mouse keratinocytes derived from miR-31 fl/fl or cKO mice in absence or presence of IL-6. Values were expressed as fold changes relative to non-stimulated HaCaT keratinocytes ( e ) or to non-stimulated NHEK ( g ) and normalized to β-actin. IL-6 was used at the concentration of 50 ng ml −1 ( b – e , g , h ). ** P <0.01, *** P <0.001, two-tailed Student's t -test. Data are representative of at least two independent experiments.

    Journal: Nature Communications

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis

    doi: 10.1038/ncomms8652

    Figure Lengend Snippet: ( a ) Undifferentiated NHEK proliferation induced by various concentrations of IL-6 for 24 h, and analysed by BrdU incorporation assay. ( b ) NHEK were transfected with scramble siRNA (Ctr) or with p65 siRNA (p65 siRNA). Cell cycle analysis of NHEK or transfected NHEK treated without or with IL-6 for 24 h. ( c ) In vitro wound healing rate of NHEK treated without or with IL-6 for 16 h. ( d , e ) Three-dimensional organotypic culture of HaCaT keratinocytes treated without or with IL-6. Scale bar, 100 μm. ( f ) 1 μg recombinant mouse IL-6 (in 25 μl PBS) or PBS was injected i.d. in ears of C57BL/6J mice. Ear sections were prepared for Ki67 staining 3 days after IL-6 administration. Scale bar, 100 μm. ( g ) NHEK were transfected with scramble siRNA (Ctr) or with p65 siRNA (p65 siRNA). Western blotting of ppp6c expression in NHEK with or without IL-6 treatment for 24 h. ( h ) Cell cycle analysis of primary mouse keratinocytes derived from miR-31 fl/fl or cKO mice in absence or presence of IL-6. Values were expressed as fold changes relative to non-stimulated HaCaT keratinocytes ( e ) or to non-stimulated NHEK ( g ) and normalized to β-actin. IL-6 was used at the concentration of 50 ng ml −1 ( b – e , g , h ). ** P <0.01, *** P <0.001, two-tailed Student's t -test. Data are representative of at least two independent experiments.

    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    Techniques: BrdU Incorporation Assay, Transfection, Cell Cycle Assay, In Vitro, Recombinant, Injection, Staining, Western Blot, Expressing, Derivative Assay, Concentration Assay, Two Tailed Test

    Mice were injected subcutaneously with an irrelevant antagomir (NC) or an antagomir to miR-31 (anti-miR-31). The first injection was administered 3 days before the application of IMQ and thereafter was performed every other day until the end of the experiment. ( a ) H&E staining of the back skin derived from mice injected with NC (upper panel) or anti-miR-31 (lower panel). Scale bar, 100 μm. ( b , c ) Acanthosis and dermal cellular infiltrates were quantitated for mice treated with NC or anti-miR-31. ( d , e ) Ppp6c mRNA and protein levels in NC- or anti-miR-31-treated mice. ( f , g ) Immunohistochemical staining of ppp6c or Ki67 in skin sections derived from NC- or anti-miR-31-treated mice after induction of skin phenotype by IMQ ( n =8–9). Scale bar, 50 μm ( f ) or 100 μm ( g ). For all measurements ( c ), the median number of specifically stained dermal nucleated cells was counted in three high-power fields per section. Results ( d ) are presented as the ratio of mRNA to the β-actin, relative to that in NC-treated mice. * P <0.05, *** P <0.001, two-tailed Student's t -test. Data ( a – g ) are representative of at least two independent experiments with four to nine samples per group in each (mean and s.e.m.).

    Journal: Nature Communications

    Article Title: NF-κB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis

    doi: 10.1038/ncomms8652

    Figure Lengend Snippet: Mice were injected subcutaneously with an irrelevant antagomir (NC) or an antagomir to miR-31 (anti-miR-31). The first injection was administered 3 days before the application of IMQ and thereafter was performed every other day until the end of the experiment. ( a ) H&E staining of the back skin derived from mice injected with NC (upper panel) or anti-miR-31 (lower panel). Scale bar, 100 μm. ( b , c ) Acanthosis and dermal cellular infiltrates were quantitated for mice treated with NC or anti-miR-31. ( d , e ) Ppp6c mRNA and protein levels in NC- or anti-miR-31-treated mice. ( f , g ) Immunohistochemical staining of ppp6c or Ki67 in skin sections derived from NC- or anti-miR-31-treated mice after induction of skin phenotype by IMQ ( n =8–9). Scale bar, 50 μm ( f ) or 100 μm ( g ). For all measurements ( c ), the median number of specifically stained dermal nucleated cells was counted in three high-power fields per section. Results ( d ) are presented as the ratio of mRNA to the β-actin, relative to that in NC-treated mice. * P <0.05, *** P <0.001, two-tailed Student's t -test. Data ( a – g ) are representative of at least two independent experiments with four to nine samples per group in each (mean and s.e.m.).

    Article Snippet: Mouse anti-actin Ab (1:3,000; Cell Signaling Technology, #3700S), rabbit anti-ppp6c Ab (1:1,000; Abcam, #EPR8764), rat anti-p65 Ab (Cell Signaling Technology, #8242S) and rabbit anti-mouse Ki67 Ab (eBioscience, #42–5698) were used.

    Techniques: Injection, Staining, Derivative Assay, Immunohistochemical staining, Two Tailed Test